Shares of Relx Plc (NYSE:RELX – Get Free Report) have been given a consensus recommendation of “Buy” by the eight analysts that are presently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and two have issued a strong buy recommendation on the company.
RELX has been the topic of several analyst reports. Wall Street Zen lowered shares of Relx from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Relx in a report on Monday, December 29th. Zacks Research upgraded Relx from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 6th. Deutsche Bank Aktiengesellschaft upgraded Relx from a “hold” rating to a “buy” rating in a research report on Tuesday, December 9th. Finally, Barclays reiterated an “overweight” rating on shares of Relx in a research report on Tuesday, October 7th.
View Our Latest Stock Analysis on RELX
Institutional Trading of Relx
Relx Stock Up 0.1%
Shares of Relx stock opened at $39.88 on Friday. The company has a current ratio of 0.47, a quick ratio of 0.42 and a debt-to-equity ratio of 2.55. Relx has a 12-month low of $39.18 and a 12-month high of $56.33. The firm’s 50-day moving average price is $40.76 and its two-hundred day moving average price is $45.25.
Relx Company Profile
RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.
RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.
Featured Stories
- Five stocks we like better than Relx
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- The $100 Trillion AI Story No One Is Telling You
- Buy This Stock at 9:30 AM on MONDAY!
- A U.S. “birthright” claim worth trillions – activated quietly
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.
